Advisory Board / Tom Shi, Ph.D.
Tom (Tong) Shi, Ph.D. Pharm.D. is a Harvard- and Yale-trained Biochemist and Immunologist. He have led research efforts to understand the pathogenesis of Autism, especially Fragile X-Syndrome, at Seaside Therapeutics, which was engaged in developing Fragile X-syndrome treatment.
He has investigated the interaction between the Immune system and autistic neurons and discovered a significant inference of autistic neurons on the Immune system. He also discovered a set of plasma protein biomarkers distinguishing autistic individuals from normal populations.